4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0001681171-16-000002
$BHCCIK 0000885590operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 8:48 PM ET
Size
5.1 KB
Accession
0001681171-16-000002
Insider Transaction Report
Form 4
KAVANAGH SARAH B
Director
Transactions
- Award
Common Stock, no par value
2016-07-27+14,458→ 14,458 total
Footnotes (2)
- [F1]Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]Prorated annual grant of restricted stock units equal to $339,640. Pricing is based on the closing price of registrant common stock on the date of grant.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 8:48 PM ET
- Size
- 5.1 KB